Fenwick Represents Akido Labs in $60M Series B Funding

Fenwick represented Akido Labs, an AI and healthcare delivery company, in its $60 million Series B funding. The round was led by Oak HC/FT with participation from Greco, SNR, and existing investors Y Combinator, Future Communities Capital, Jeff Dean (Chief Scientist, Google DeepMind & Google Research), and the Comprehensive Blood & Cancer Center.

Akido Labs will use the funds to expand the reach of ScopeAI, a system that increases clinical capacity and improves healthcare access. More information can be obtained here.

The Fenwick transaction team was led by corporate partners Matt Rossiter and Will Black and included associates David Rand, Kaylee Johnson, Kate Souza, and Brian Honaker-Coe.